Steve, hard to say for sure, but there are a number of signs the company is about to be sold: interim CEO for nine months now (If they intended to stay independent they would have hired a CEO by now or make TL permanent); five of the top execs removed from all material last week and the company is not responding to inquires on it (If they were still there a simple conformation by IR would be in line, but they may be avoiding the issue if the execs were removed as part of a deal); Bonstein recently wrote article touting how important CFOs are in drug development (it came across as something she wrote to help find her next job)